Thursday, July 31

In a recent discussion among the panelists of Barron’s Roundtable, 23andMe, the well-known genetics testing company, faced considerable scrutiny amid significant operational changes. The company announced on Monday that it would cut its workforce by 40%, which translates to more than 200 employees. This decision comes in the wake of an urgent need to restructure...

Premium Membership Required

You must be a Premium member to access this content.

Join Now

Already a member? Log in here
Share.

Comments are closed.

Exit mobile version